Topics

No keywords indexed for this article. Browse by subject →

References
22
[1]
Aldieri "Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation" FEBS Lett. (2003) 10.1016/s0014-5793(03)00905-0
[2]
Bales "The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation" Brain Res. Mol. Brain Res. (1998) 10.1016/s0169-328x(98)00066-7
[3]
Bork "Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-kappaB" FEBS Lett. (1997) 10.1016/s0014-5793(96)01502-5
[4]
Choi "Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappa B pathway and downstream enzymes involved in prostaglandin biosynthesis" J. Neurochem. (2006) 10.1111/j.1471-4159.2006.03926.x
[5]
Cleren "Celastrol protects against MPTP and 3-nitropropionic acid-induced neurotoxicity" J. Neurochem. (2005) 10.1111/j.1471-4159.2005.03253.x
[6]
Evin "Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets" J. Neurosci. Res. (2003) 10.1002/jnr.10745
[7]
Ferrer "NF-kB immunoreactivity is observed in association with beta A4 diffuse plaques in patients with Alzheimer's disease" Neuropathol. Appl. Neurobiol. (1998) 10.1046/j.1365-2990.1998.00116.x
[8]
Hidalgo "Andrographolide interferes with binding of nuclear factor-kappaB to DNA in HL-60-derived neutrophilic cells" Br. J. Pharmacol. (2005) 10.1038/sj.bjp.0706105
[9]
Hoozemans "The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs" Curr. Drug Targets CNS Neurol. Disord. (2005) 10.2174/1568007054038201
[10]
Jin "Anti inflammatory constituents of Celastrus orbiculatus inhibit the NF-kappaB activation and NO production" J. Nat. Prod. (2002) 10.1021/np010428r
[11]
Kaltschmidt "Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease" Proc. Natl. Acad. Sci. U.S.A. (1997) 10.1073/pnas.94.6.2642
[12]
Kukar "Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production" Nat. Med. (2005) 10.1038/nm1235
[13]
Lee "Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes" J. Biol. Chem. (2002) 10.1074/jbc.m201368200
[14]
Lin "Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence" J. Biol. Chem. (1995) 10.1074/jbc.270.24.14255
[15]
Natarajan "Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B" Proc. Natl. Acad. Sci. U.S.A. (1996) 10.1073/pnas.93.17.9090
[16]
Selkoe "Amyloid beta-peptide is produced by cultured cells during normal metabolism: a reprise" J. Alzheimer Dis. (2006) 10.3233/jad-2006-9s319
[17]
Sinha "Cellular mechanisms of beta-amyloid production and secretion" Proc. Natl. Acad. Sci. U.S.A. (1999) 10.1073/pnas.96.20.11049
[18]
Sung "Modulation of nuclear factor-kappa B activity by indomethacin influences Abeta levels but not Abeta precursor protein metabolism in a model of Alzheimer's disease" Am. J. Pathol. (2004) 10.1016/s0002-9440(10)63269-5
[19]
Terai "Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease" Brain Res. (1996) 10.1016/0006-8993(96)00310-1
[20]
Tobe "Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation" Bioorg. Med. Chem. (2003) 10.1016/s0968-0896(02)00440-6
[21]
Verma "Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation" Genes Dev. (1995) 10.1101/gad.9.22.2723
[22]
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

Sascha Weggen, Jason L. Eriksen, Pritam Das et al.

Nature 2001 10.1038/35102591
Metrics
63
Citations
22
References
Details
Published
Mar 01, 2007
Vol/Issue
415(1)
Pages
11-16
License
View
Cite This Article
Daniel Paris, Nikunj Patel, Amita Quadros, et al. (2007). Inhibition of Aβ production by NF-κB inhibitors. Neuroscience Letters, 415(1), 11-16. https://doi.org/10.1016/j.neulet.2006.12.029